STOCK TITAN

Tenon Medical, Inc. - TNON STOCK NEWS

Welcome to our dedicated page for Tenon Medical news (Ticker: TNON), a resource for investors and traders seeking the latest updates and insights on Tenon Medical stock.

Tenon Medical, Inc. (TNON) delivers innovative solutions for sacroiliac joint disorders through its Catamaran™ System. This page provides authorized updates on clinical advancements, regulatory milestones, and strategic developments directly from the company and verified sources.

Investors and medical professionals will find comprehensive coverage of FDA clearances, peer-reviewed study results, and partnership announcements. Our curated news collection features earnings reports, product launch details, and analysis of market expansion efforts in minimally invasive spine technology.

Key updates include progress in post-market clinical studies, intellectual property developments, and educational initiatives for surgeons. All content undergoes strict verification to ensure alignment with financial disclosure regulations and medical accuracy standards.

Bookmark this page for real-time updates on TNON's pioneering work in SI joint fusion technology. For direct access to corporate filings and investor resources, visit the official Tenon Medical website through our verified links.

Rhea-AI Summary
Tenon Medical, Inc. (NASDAQ: TNON) announced participation in two recent immersive physician webinar training programs featuring the Company's Catamaran SI Joint Fusion System. Dr. Matthew Davies led the training programs discussing his clinical experience with the system in over 50 Catamaran procedures. The programs attracted over 60 health care providers and featured discussion on proper patient selection, procedural outcomes, and the advantages of the Catamaran Fixation Device.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.3%
Tags
none
-
Rhea-AI Summary
Tenon Medical, Inc. (TNON) issued $1.25 million in Secured Notes and warrants to purchase 45,000 shares of common stock in a private placement led by Ascent Special Ventures. The Notes accrue 10% interest and are prepayable at any time. The Warrants have a five-year term and an exercise price of $1.94. The investment will provide additional liquidity for commercializing Tenon's SI Joint Fusion devices, supporting the company's mission to innovate treatments for sacroiliac joint disorders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.88%
Tags
none
-
Rhea-AI Summary
Tenon Medical, Inc. (NASDAQ: TNON) reported a 354% year-over-year revenue increase to $944,000 in Q3 2023. Gross profit margin rose to 57%, a 31 basis points sequential increase. Surgical procedures using the Catamaran System surged by 329%. The company concluded the quarter with the surgical launch of the JIB Instrument Kit, and secured a $10 million equity line of credit facility with Lincoln Park Capital Fund. Additionally, Tenon passed FDA's Level 2 Quality System Inspection with no observations, objectionable conditions, or Form 483 issued.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.42%
Tags
Rhea-AI Summary
Tenon Medical, Inc. announced that the US Food and Drug Administration (FDA) has concluded a full Quality System Inspection Technique (QSIT) Level 2 Inspection at Tenon Medical. The inspection found no objectionable conditions or violations of the Food Drug and Cosmetic (FD&C) Act. Tenon Medical received a Pass, indicating their focus on quality and strict operational procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
49.41%
Tags
none
-
Rhea-AI Summary
Tenon Medical, Inc. (NASDAQ:TNON) plans to release its financial results for Q3 2023 on November 14, 2023, after market close. A conference call will be held at 4:30 p.m. Eastern Time on the same day to discuss the results. Dial-in details and webcast information are provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Tenon Medical, Inc. announces a 1:10 reverse stock split of its common stock to increase the per share market price and meet the listing requirements of the Nasdaq Capital Market. The split will be effective on November 2, 2023, and the new trading symbol will be 'TNON'.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-38.85%
Tags
none
Rhea-AI Summary
Tenon Medical expands use of JIB instrument kit for Catamaran fixation device, successfully performed cases at Zion Surgery Center
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.5%
Tags
none
-
Rhea-AI Summary
Tenon Medical, Inc. withdraws proposed public offering of common stock
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25.69%
Tags
-
Rhea-AI Summary
Tenon Medical announces proposed public offering of common stock. All shares being offered by Tenon. Offering subject to market conditions. Maxim Group LLC acting as sole placement agent.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-45.25%
Tags
Rhea-AI Summary
Tenon Medical reports Q2 2023 revenue of $743,000, a 450% YoY increase. Gross profit turns positive at 26%. 469% increase in surgical procedures using The Catamaran System. Closed $5.6 million public offering. Cash and cash equivalents at $6.3 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.93%
Tags
Tenon Medical, Inc.

Nasdaq:TNON

TNON Rankings

TNON Stock Data

5.63M
6.18M
1.63%
4.19%
5.3%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
LOS GATOS